Jing Liang

Stereospecific Synthesis, Structure−Activity Relationship, and Oral Bioavailability of Tetrahydropyrimidin-2-one HIV Protease Inhibitors

George V. De Lucca, Jing Liang, Indawati De Lucca · Journal of Medicinal Chemistry · 1998 · 54 citations · Full text

Pharmaceutical Science, Oral Bioavailability, Stereospecific Synthesis +20

PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids

Yanli Wu, Yueying Yang, Wang Wang et al. · Acta Pharmaceutica Sinica B · 2022 · 53 citations · Full text

Proteinlipid Interaction, Biochemistry, Bioassay-guided Isolation +7

Nonsymmetric P2/P2‘ Cyclic Urea HIV Protease Inhibitors. Structure−Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues

George V. De Lucca, Ui T. Kim, Jing Liang et al. · Journal of Medicinal Chemistry · 1998 · 50 citations · Full text

Hivpr Inhibitors, Antiviral Drug, Chemical Biology +19

Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors

George V. De Lucca, Jing Liang, Paul E. Aldrich et al. · Journal of Medicinal Chemistry · 1997 · 46 citations · Full text

Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes

J J Zhang, Yingchao Hou, Jinjin Lu et al. · Biomaterials · 2023 · 32 citations

Signal Transduction, Cell Trafficking, Immunology +8